Health Condition 1: N390- Urinary tract infection, site notspecified
Conditions
Interventions
Intervention1: Terebinthinae Oleum 30 CH: The study included a seven-day treatment period with Terebinthinae Oleum 30 CH and
a 30-day follow-up period.
Minimum of Four (4) visits were planned
Contro
Sponsors
Sibin R A
Eligibility
Inclusion criteria
Inclusion criteria: Clinical signs with one or more symptoms of a UTI. Onset of symptoms < 24 hours prior to study entry
Exclusion criteria
Exclusion criteria: Three or more episodes of acute UTI in the past 12 months; Known structural Genito-urinary abnormality patients Patients with evidence of factors like calculi, stricture, primary renal disease (e.g., polycystic renal disease), or neurogenic bladder; Patients with significant impaired immunity secondary to chemotherapy, oral corticosteroids. Patients with onset of symptoms > 24 hours prior to entry. Patients with temperature â�¥ 103�°F. Patients who received treatment with other antimicrobials within 48 hours prior to enrollment. Any significant medical or psychiatric condition that would render examination difficult or invalid or prevent the subject from active study participation. Patients under other medications or concomitant therapies which interfere the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of Microbiological response during the therapeutic interventionTimepoint: three to seven days | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of microbiological outcome per participant involved in the studyTimepoint: seven to thirty seven days | — |
Countries
India
Contacts
Public ContactSibin R A
Sarada Krishna Homoeopathic Medical College and Hospital
Outcome results
None listed